Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Irsogladine maleate and its clinical effects on portal hypertensive gastropathy associated with cirrhosis
TCTR20250311002Phase 4Completed
- Sponsor
- Bhumibol Adulyadej Hospital
- Start
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of irsogladine in portal hypertensive gastropathy (PHG), Cirrhosis, sponsored by Bhumibol Adulyadej Hospital. Started Dec 2023; status: completed.
02
Drugs
irsogladine
03
Conditions
portal hypertensive gastropathy (PHG)Cirrhosis
Beyond the preview
Go deeper on TCTR20250311002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20250311002.